Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats

Hepatotoxic Botanicals - An Evidence-based Systematic Review

(2016) Reem J Abdualmjid et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

(2015) Haiqiang Cao et al.   MOLECULAR PHARMACEUTICS

Cytochrome P450-Mediated Biotransformation of Sorafenib and Its N-Oxide Metabolite: Implications for Cell Viability and Human Toxicity

(2014) Tina B. Gillani et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein

(2014) Young-Ah Cho et al.   Pharmacological Reports

Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats

(2014) Na Gao et al.   PLoS One

Sorafenib and triptolide as combination therapy for hepatocellular carcinoma

(2014) Osama A. Alsaied et al.   SURGERY

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

(2013) Roberto Iacovelli et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Gentiopicroside: Potent Effect on CYP2A6

(2013) Yating Deng et al.   Drug Metabolism and Pharmacokinetics

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma

(2012) BP Fairfax et al.   BMC CANCER

Ontogeny and Sorafenib Metabolism

(2012) E. I. Zimmerman et al.   CLINICAL CANCER RESEARCH

Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review

(2012) Bingru Xie et al.   DIGESTIVE DISEASES AND SCIENCES

Severe Pazopanib-Induced Hepatotoxicity: Clinical and Histologic Course in Two Patients

(2012) Samuel J. Klempner et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus Infection

(2011) Chang-Hsing Lee et al.   PLoS One

Hepatocellular carcinoma: diagnostics and screening

(2010) Madhvi Patel et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Sorafenib-Induced Severe Acute Hepatitis in a Stable Liver Transplant Recipient

(2010) Uta Herden et al.   TRANSPLANTATION

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

(2009) Onder Tonyali et al.   MEDICAL ONCOLOGY

Acute Hepatitis in a Patient With Cirrhosis and Hepatocellular Carcinoma Treated With Sorafenib

(2008) Lucia Llanos et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

(2008) Vandana Gupta-Abramson et al.   JOURNAL OF CLINICAL ONCOLOGY

Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan

(2008) Fang-Pey Chen et al.   JOURNAL OF ETHNOPHARMACOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL